Decreases in CD5+ B lymphocytes in children with the DiGeorge anomaly

Scandinavian Journal of Immunology

Volumn 46, Issue 3, 1997, Pages 281-283

  Kourtis, A P ^a   Ibegbu, C C ^a   Lee, F K ^a   Vogler, L ^a   Philips, K ^a   Nahmias, A J ^a,b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Division of Infectious Diseases   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; B LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIGEORGE SYNDROME; HUMAN; INFANT; LYMPHOCYTE COUNT; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030757726     PISSN: 03009475     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3083.1997.d01-127.x     Document Type: Article

References (18)

1. Hong R. The DiGeorge anomaly. Immunodef Rev 1991;3:1-14.
2. Hall JG. Catch 22. Medical Genetics 1993;30:801-2.
3. Bastian J, Law S, Vogler L et al. Prediction of persistent immuno-deficiency in the DiGeorge anomaly. J Pediatr 1989;115:391-6.
4. Driscoll D, Budard M, Emanuel B. A genetic etiology for DiGeorge syndrome: consistent deletions and microdeletions of 22q11. Am J Hum Genet 1992;50:924-33.
5. Ibegbu C, Spira T, Nesheim S, Caba J, Lee FK, Nahmias AJ. Subpopulations of T and B cells in perinatally HIV-infected and noninfected age-matched children compared with those in adults. Clin Immunol Immunopathol 1994;1:27-32.
6. Muller W, Peter H, Kallfelz H. The DiGeorge sequence. Immunologic findings in partial and complete forms of the disorder. Eur J Pediatr 1989;149:96-103.
7. Rosen FS. Defects in cell-mediated immunity. Clin Immunol Immunopathol 1989;41:1-7.
8. Durandy A, LeDeist F, Fischer A, Griscell C. Impaired T8 lymphocyte-mediated suppressive activity in patients with partial DiGeorge syndrome. J Clin Immunol 1986;6:265-70.
9. Herzenberg LA, Kantor AB, Herzenberg LA. Layered evolutions in the immune system: a model for the ontogeny and development of multiple lymphocyte lineages. Ann NY Acad Sci 1992;651: 1-9.
10. - B lymphocytes. Int Immunol 1990;2:603-14.
11. + B cells in normal newborns and infants, and in those with HIV and intrauterine infections. Ann NY Acad Sci 1992;651:572-5.
12. Nango K, Inaba M, Inaba K et al. Ontogeny of thymic B cells in normal mice. Cell Immunol 1991;133:109-15.
13. Isaacson P, Norton A, Addis B. The human thymus contains a novel population of B lymphocytes. Lancet 1987;2:1488.
14. + B cells. Responsiveness to major histocompatibility complex class II-restricted T blasts but not to lipopolysaccharide or anti-IgM plus interleukin 4. J Exp Med 1990;171:321-6.
15. + B cells in experimental autoimmune encephalomyelitis. Ann NY Acad Sci 1992;651:579-80.
16. Kourtis AP, Ibegbu C, Nahmias AJ et al. Early progression of disease in HIV-infected infants with thymus dysfunction. N Engl J Med 1996;335:1431-6.
17. Nahmias A, Clark S, Kourtis AP, Lee FK, Simmonds RJ, Nesheim SR. Thymic dysfunction associated with early development of AIDS and mortality in HIV-infected infants. In: Program and Abstracts, 4th Conference on Retroviruses and Opportunistic Infections, Washington, DC, January 22-26, 1997, abstract.
18. Nahmias AJ, Hong R, Nesheim S et al. Thymic transplantation in pediatric AIDS. In: Program and Abstracts of the 1995 International Symposium on Clinical Immunology, San Fransisco, July 20-23, 1995. New York: Clinical Immunology Society, 1995, abstract.